These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 1603169)
1. [Bladder carcinoma]. Lycklama à Nijeholt AA Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1097-102. PubMed ID: 1603169 [No Abstract] [Full Text] [Related]
2. Bladder cancer. Gwynn ES; Clark PE Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241 [TBL] [Abstract][Full Text] [Related]
3. [Treatment and follow-up of superficial bladder cancer]. Raitanen M Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168 [No Abstract] [Full Text] [Related]
4. Diagnosis and treatment of bladder cancer. Sharma S; Ksheersagar P; Sharma P Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art]. Kausch von Schmeling I Aktuelle Urol; 2010 Sep; 41(5):307-15. PubMed ID: 20824576 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder. Simon SD; Srougi M Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415 [No Abstract] [Full Text] [Related]
7. Bladder cancer: clinical practice. Rabinowits G; Laber DA J Ky Med Assoc; 2009 Apr; 107(4):129-33. PubMed ID: 19419018 [No Abstract] [Full Text] [Related]
9. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group. Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422 [No Abstract] [Full Text] [Related]
10. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729 [TBL] [Abstract][Full Text] [Related]
11. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma. Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737 [TBL] [Abstract][Full Text] [Related]
12. [Our experience in treating patients with surface cancer of the bladder]. Matveev BP; Figurin KM; Romanov VA; Cheban NL Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484 [TBL] [Abstract][Full Text] [Related]
13. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony]. Steinbach F; Schuster F Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407 [TBL] [Abstract][Full Text] [Related]
14. [Squamous cell carcinoma of the urinary bladder after intravesical bacillus Calmette-Guerin therapy for carcinoma in situ: a case report]. Uemura M; Nishimura K; Nakagawa M; Kanno N; Miyoshi S; Kawano K; Inoue H Hinyokika Kiyo; 2004 Nov; 50(11):809-11. PubMed ID: 15628544 [TBL] [Abstract][Full Text] [Related]
15. Contemporary management of stage T1 transitional cell carcinoma of the bladder. Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077 [No Abstract] [Full Text] [Related]
16. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin. Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815 [TBL] [Abstract][Full Text] [Related]